RB-3007
Synthetic cannabinoid
| Drug Information | |||
|---|---|---|---|
| Image | |||
| Identifiers
CAS Number ATC Code DrugBank UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
| ||
RB-3007 is a synthetic cannabinoid that has been used in scientific research. It is a potent agonist of the CB1 receptor and CB2 receptor, which are part of the endocannabinoid system. Synthetic cannabinoids like RB-3007 are often used to study the effects of cannabinoid receptor activation in various physiological and pathological processes.
Chemical Structure[edit | edit source]
RB-3007 has a chemical structure that includes a 1-(5-fluoropentyl)-1H-indol-3-yl group and a 2,2,3,3-tetramethylcyclopropyl methanone group. This structure is similar to other synthetic cannabinoids, which often feature an indole or indazole core linked to various side chains.
Pharmacology[edit | edit source]
RB-3007 acts as a full agonist at both the CB1 receptor and CB2 receptor. The activation of these receptors can lead to a variety of effects, including analgesia, anti-inflammatory effects, and psychoactive effects. The potency and efficacy of RB-3007 at these receptors make it a valuable tool for research into the endocannabinoid system.
Research Applications[edit | edit source]
RB-3007 is primarily used in preclinical research to investigate the role of the endocannabinoid system in health and disease. Studies using RB-3007 can help to elucidate the mechanisms by which cannabinoid receptors influence pain, inflammation, and neurological disorders.
Legal Status[edit | edit source]
The legal status of RB-3007 varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and psychoactive effects. Researchers must ensure they comply with local regulations when working with this compound.
Safety and Toxicology[edit | edit source]
As with many synthetic cannabinoids, the safety profile of RB-3007 is not well-established. Potential risks include cardiovascular effects, neurotoxicity, and psychotropic effects. Proper safety protocols should be followed when handling and experimenting with this compound.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
